NBIX - Neurocrine Biosciences CEO Gorman stepping down in October
2024-05-28 16:30:06 ET
More on Neurocrine Biosciences
- Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
- Neurocrine Q1 revenue beats Street, gets FDA okay for Ingrezza Sprinkle
- Neurocrine Biosciences Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Neurocrine Biosciences